文献速递神经MRDSA

高分辨率颅内血管壁成像中的血管壁增厚与强化:烟雾病未来缺血事件的预测因素

Vessel Wall Thickening and Enhancement in High-Resolution Intracranial Vessel Wall Imaging: A Predictor of Future Ischemic Events in Moyamoya Disease.
PubMed 文献 · AJNR Am J Neuroradiol · 2020-01-02

本研究纳入29例经DSA确诊的烟雾病患者(含血运重建术后),行高分辨率颅内血管壁成像,评估双侧颈内动脉远端及大脑中动脉近端血管壁增厚、强化及重构指数,并在3个月和6个月随访缺血事件。结果显示,对比强化(P=0.01)和血管壁增厚(P≤0.001)与血管壁成像前后3个月内的缺血事件显著相关,II级强化与成像后4周内的缺血事件显著相关(P=0.02)。作者认为血管壁增厚和强化可能预测烟雾病患者的未来缺血事件。

要点

  • 烟雾病患者高分辨率血管壁成像中,同心性管壁增厚(6.6%)和强化相对少见。
  • 对比强化(P=0.01)和管壁增厚(P≤0.001)与成像前后3个月内缺血事件显著相关。
  • II级强化与成像后4周内缺血事件显著相关(P=0.02)。

关键影像表现/征象

  • 高分辨率颅内血管壁成像共检出166个狭窄-闭塞性病变。
  • 9例患者中检出11个同心性管壁增厚病变(6.6%)。
  • 8例患者中观察到10个同心性对比强化病变,其中3例患者(4个病变)表现为II级强化。
  • 烟雾病患者颈内动脉远端平均外径(右侧-3.3±0.68 mm;左侧3.4±0.60 mm)和重构指数(右侧0.71±0.13;左侧0.69±0.13)较低。

诊断标准与关键数值

  • 对比强化的存在与血管壁成像前后3个月内缺血事件显著相关(P=0.01)。
  • 管壁增厚的存在与血管壁成像前后3个月内缺血事件显著相关(P≤0.001)。
  • II级强化与高分辨率颅内血管壁成像后4周内缺血事件显著相关(P=0.02)。

临床应用与阅片要点

  • 作者认为,管壁增厚和强化的存在可能预测烟雾病患者的未来缺血事件。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Very few data are available with regard to high-resolution intracranial vessel wall imaging characteristics of Moyamoya disease and their relation to ischemic stroke risk. We investigated the high resolution imaging characteristics of MMD and its correlation with recent ischemic events.

MATERIALS AND METHODS: Patients with Moyamoya disease confirmed by DSA, including patients after revascularization, were enrolled. All the patients underwent high-resolution intracranial vessel wall imaging. Vessel wall thickening, enhancement, and the remodeling index of the bilateral distal ICA and proximal MCA were noted. The patients were followed up at 3 months and 6 months after high-resolution intracranial vessel wall imaging and the association of ischemic events with imaging characteristics was assessed.

RESULTS: Twenty-nine patients with Moyamoya disease were enrolled. The median age at symptom onset was 12 years (range, 1-51 years). A total of 166 steno-occlusive lesions were detected by high-resolution intracranial vessel wall imaging. Eleven lesions with concentric wall thickening (6.6%) were noted in 9 patients. Ten concentric contrast-enhancing lesions were observed in 8 patients, of which 3 patients (4 lesions) showed grade II enhancement. The presence of contrast enhancement (P = .01) and wall thickening (P ≤ .001) showed a statistically significant association with ischemic events within 3 months before and after the vessel wall imaging. Grade II enhancement showed a statistically significant (P = .02) association with ischemic events within 4 weeks of high-resolution intracranial vessel wall imaging. The mean ± standard deviation outer diameter of the distal ICA (right, -3.3 ± 0.68 mm; left, 3.4 ± 0.60 mm) and the remodeling index (right, 0.71 ± 0.13; left, 0.69 ± 0.13) were lower in Moyamoya disease.

CONCLUSIONS: High-resolution intracranial vessel wall imaging characteristics of concentric wall thickening and enhancement are relatively rare in our cohort of patients with Moyamoya disease. The presence of wall thickening and enhancement may predict future ischemic events in patients with Moyamoya disease.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Kathuveetil A, Sylaja PN, Senthilvelan S, et al. Vessel Wall Thickening and Enhancement in High-Resolution Intracranial Vessel Wall Imaging: A Predictor of Future Ischemic Events in Moyamoya Disease. AJNR Am J Neuroradiol. 2020. PMID: 31896569. doi:10.3174/ajnr.A6360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。